Phase 2 study of pelacarsen (ISIS 681257; AKCEA-APO(a)-LRx) in participants with hyperlipoproteinemia(a) and cardiovascular disease

Educational Partners and Supporters

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum. (Founding Partner)